The Impact of Estradiol and 1,25(OH)2D3 on Metabolic Syndrome in Middle-Aged Taiwanese Males

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Cheng, Kai Hung ^a,b   Huang, Shu Pin ^a,b   Huang, Chun Nung ^a,b   Lee, Yung Chin ^a,b   Chu, Chih Sheng ^a,b   Chang, Chu Fen ^c   Lai, Wen Ter ^a,b   Liu, Chia Chu ^a,b,d  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c TZU CHI UNIVERSITY   (Taiwan)

^d Pingtung Hospital   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CALCITRIOL; ESTRADIOL; LEPTIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREDICTION; RISK FACTOR; TAIWAN;

ADIPONECTIN; ADULT; AGED; CROSS-SECTIONAL STUDIES; ESTRADIOL; HUMANS; LEPTIN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; RADIOIMMUNOASSAY; VITAMIN D;

EID: 84875503810     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060295     Document Type: Article

References (71)

1. Ballantyne CM, Hoogeveen RC, McNeill AM, Heiss G, Schmidt MI, et al. (2008) Metabolic syndrome risk for cardiovascular disease and diabetes in the ARIC study. Int J Obes (Lond) 32: S21-24.
2. Assmann G, Schulte H, Seedorf U, (2008) Cardiovascular risk assessment in the metabolic syndrome: results from the Prospective Cardiovascular Munster (PROCAM) Study. Int J Obes (Lond) 32: S11-16.
3. Lee YC, Liu CC, Huang CN, Li WM, Wu WJ, et al. (2010) The Potential Impact of Metabolic Syndrome on Erectile Dysfunction in Aging Taiwanese Males. J Sex Med 7 (9) ():: 3127-34.
4. Ginsberg HN, MacCallum PR, (2009) The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: Part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus. J Cardiometab Syndr 4: 113-119.
5. Malik S, Wong ND, (2009) Metabolic syndrome, cardiovascular risk and screening for subclinical atherosclerosis. Expert Rev Cardiovasc Ther 7: 273-280.
6. Huang PL, (2009) eNOS, metabolic syndrome and cardiovascular disease. Trends Endocrinol Metab 20: 295-302.
7. Huang PL, (2009) A comprehensive definition for metabolic syndrome. Dis Model Mech 2: 231-237.
8. Deng JY, Hsieh PS, Huang JP, Lu LS, Hung LM, (2008) Activation of estrogen receptor is crucial for resveratrol-stimulating muscular glucose uptake via both insulin-dependent and-independent pathways. Diabetes 57: 1814-1823.
9. Matyšková R, Zelezná B, Maixnerová J, Koutová D, Haluzík M, et al. (2010) Estradiol supplementation helps overcome central leptin resistance of ovariectomized mice on a high fat diet. Horm Metab Res 42: 182-186.
10. Frankel DS, Vasan RS, D'Agostino RB Sr, Benjamin EJ, Levy D, et al. (2009) Resistin, Adiponectin, and Risk of Heart Failure: The Framingham Offspring Study. J Am Coll Cardiol 53: 754-762.
11. Ziemke F, Mantzoros CS, (2010) Adiponectin in insulin resistance: lessons from translational research. Am J Clin Nutr 91: 258S-261S.
12. Barseghian A, Gawande D, Bajaj M, (2011) Adiponectin and Vulnerable Atherosclerotic Plaques. J Am Coll Cardiol 57: 761-770.
13. Cheng KH, Chu CS, Lee KT, Lin TH, Hsieh CC, et al. (2008) Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease. Int J Obes (Lond) 32: 268-274.
14. Sattar N, Wannamethee G, Sarwar N, Chernova J, Lawlor DA, et al. (2009) Leptin and Coronary Heart Disease: Prospective Study and Systematic Review. J Am Coll Cardiol 53: 167-175.
15. Söderberg S, Colquhoun D, Keech A, Yallop J, Barnes EH, et al. (2009) Leptin, but not adiponectin, is a predictor of recurrent cardiovascular events in men: results from the LIPID study. Int J Obes (Lond) 33: 123-130.
16. Conde J, Scotece M, Gómez R, Gómez-Reino JJ, Lago F, et al. (2010) At the crossroad between immunity and metabolism: focus on leptin. Expert Rev Clin Immunol 6: 801-808.
17. Amato MC, Verghi M, Nucera M, Galluzzo A, Giordano C, (2011) Low estradiol-to-testosterone ratio is associated with oligo-anovulatory cycles and atherogenic lipidic pattern in women with polycystic ovary syndrome. Gynecol Endocrinol 27: 579-586.
18. Valkenburg O, Steegers-Theunissen RP, Smedts HP, Dallinga-Thie GM, Fauser BC, et al. (2008) A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control study. J Clin Endocrinol Metab 93: 470-476.
19. van Dam EW, Roelfsema F, Veldhuis JD, Hogendoorn S, Westenberg J, et al. (2004) Retention of estradiol negative feedback relationship to LH predicts ovulation in response to caloric restriction and weight loss in obese patients with polycystic ovary syndrome. Am J Physiol Endocrinol Metab 286: E615-620.
20. Saltiki K, Papageorgiou G, Voidonikola P, Mantzou E, Xiromeritis K, et al. (2010) Endogenous estrogen levels are associated with endothelial function in males independently of lipid levels. Endocrine 37: 329-335.
21. Judd SE, Tangpricha V, (2009) Vitamin D deficiency and risk for cardiovascular disease. Am J Med Sci 338: 40-44.
22. Botella-Carretero JI, Alvarez-Blasco F, Villafruela JJ, Balsa JA, Vázquez C, et al. (2007) Vitamin D deficiency is associated with the metabolic syndrome in morbid obesity. Clin Nutr 26: 573-580.
23. Kim MK, II Kang M, Won Oh K, Kwon HS, Lee JH, et al. (2010) The association of serum vitamin D level with presence of metabolic syndrome and hypertension in middle-aged Korean subjects. Clin Endocrinol (Oxf) 73: 330-8.
24. Lu L, Yu Z, Pan A, Hu FB, Franco OH, et al. (2009) Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care 32: 1278-1283.
25. Martini LA, Wood RJ, (2006) Vitamin D status and the metabolic syndrome. Nutr Rev 64: 479-486.
26. Gannagé-Yared MH, Chedid R, Khalife S, Azzi E, Zoghbi F, et al. (2009) Vitamin D in relation to metabolic risk factors, insulin sensitivity and adiponectin in a young Middle-Eastern population. Eur J Endocrinol 160: 965-971.
27. Nimitphong H, Chanprasertyothin S, Jongjaroenprasert W, Ongphiphadhanakul B, (2009) The association between vitamin D status and circulating adiponectin independent of adiposity in subjects with abnormal glucose tolerance. Endocrine 36: 205-210.
28. Bailey R, Cooper JD, Zeitels L, Smyth DJ, Yang JH, et al. (2007) Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes. Diabetes 56: 2616-2621.
29. Jones G, (2007) Expanding role for vitamin D in chronic kidney disease: importance of blood 25-OH-D levels and extra-renal 1alpha-hydroxylase in the classical and nonclassical actions of 1alpha,25-dihydroxyvitamin D(3). Semin Dial 20: 316-324.
30. Fichna M, Zurawek M, Januszkiewicz-Lewandowska D, Fichna P, Nowak J, (2010) PTPN22, PDCD1 and CYP27B1 polymorphisms and susceptibility to type 1 diabetes in Polish patients. Int J Immunogenet 37: 367-372.
31. Peterlik M, Cross HS, (2009) Vitamin D and calcium insufficiency-related chronic diseases: molecular and cellular pathophysiology. Eur J Clin Nutr 63: 1377-1386.
32. Nemerovski CW, Dorsch MP, Simpson RU, Bone HG, Aaronson KD, et al. (2009) Vitamin D and cardiovascular disease. Pharmacotherapy 29: 691-708.
33. Liu CC, Wu WJ, Lee YC, Wang CJ, Ke HL, et al. (2009) The prevalence of and risk factors for androgen deficiency in aging Taiwanese men. J Sex Med 6: 936-946.
34. Liu CC, Huang SP, Wu WJ, Chou YH, Juo SH, et al. (2009) The impact of cigarette smoking, alcohol drinking and betel quid chewing on the risk of calcium urolithiasis. Ann Epidemiol 19: 539-545.
35. Lee CH, Wu DC, Lee JM, Wu IC, Goan YG, et al. (2007) Anatomical subsite discrepancy in relation to the impact of the consumption of alcohol, tobacco and betel quid on esophageal cancer. Int J Cancer 120: 1755-1762.
36. Ponholzer A, Temml C, Rauchenwald M, Madersbacher S, (2006) Vascular risk factors and erectile dysfunction in a cohort of healthy men. Int J Impot Res 18: 489-493.
37. Hwang LC, Bai CH, Chen CJ, (2006) Prevalence of obesity and metabolic syndrome in Taiwan. J Formos Med Assoc 105: 626-635.
38. Rinaldi S, Geay A, Déchaud H, Biessy C, Zeleniuch-Jacquotte A, et al. (2002) Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations. Cancer Epidemiol Biomarkers Prev 11: 1065-1071.
39. Clapauch R, Mattos TM, Silva P, Marinheiro LP, Buksman S, (2009) Total estradiol, rather than testosterone levels, predicts osteoporosis in aging men. Arq Bras Endocrinol Metabol 53: 1020-1025.
40. Arnal JF, Laurell H, Fontaine C, Billon A, Calippe B, et al. (2009) Estrogen receptor actions on vascular biology and inflammation: implications in vascular pathophysiology. Climacteric 12 Suppl 1: 12-17.
41. Saunier EF, Vivar OI, Rubenstein A, Zhao X, Olshansky M, et al. (2011) Estrogenic plant extracts reverse weight gain and fat accumulation without causing mammary gland or uterine proliferation. PLoS One 6 (12) ().
42. Chang-Quan H, Bi-Rong D, Ping H, Zhen-Chan L, Xiao-Dong P, (2008) Insulin resistance, renal injury, renal 1-alpha hydroxylase, and bone homeostasis in aged obese rats. Arch Med Res 39: 380-387.
43. Maffei L, Rochira V, Zirilli L, Antunez P, Aranda C, et al. (2007) A novel compound heterozygous mutation of the aromatase gene in an adult man: reinforced evidence on the relationship between congenital oestrogen deficiency, adiposity and the metabolic syndrome. Clin Endocrinol (Oxf) 67: 218-224.
44. Maggio M, Lauretani F, Ceda GP, Bandinelli S, Basaria S, et al. (2010) Estradiol and metabolic syndrome in older italian men: The InCHIANTI Study. J Androl 31: 155-162.
45. Teede H, Deeks A, Moran L, (2010) Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med 8.
46. Pentikäinen V, Erkkilä K, Suomalainen L, Parvinen M, Dunkel L, (2000) Estradiol acts as a germ cell survival factor in the human testis in vitro. J Clin Endocrinol Metab 85: 2057-2067.
47. Xing D, Nozell S, Chen YF, Hage F, Oparil S, (2009) Estrogen and mechanisms of vascular protection. Arterioscler Thromb Vasc Biol 29: 289-295.
48. Gilliver SC, (2010) Sex steroids as inflammatory regulators. J Steroid Biochem Mol Biol 120: 105-115.
49. Denti L, (2010) The hormone replacement therapy (HRT) of menopause: focus on cardiovascular implications. Acta Biomed 81 Suppl 1: 73-76.
50. Shufelt CL, Bairey Merz CN, (2009) Contraceptive hormone use and cardiovascular disease. J Am Coll Cardiol 53: 221-231.
51. Qiao X, McConnell KR, Khalil RA, (2008) Sex steroids and vascular responses in hypertension and aging. Gend Med 5 Suppl A pp. S46-64.
52. Deng JY, Hsieh PS, Huang JP, Lu LS, Hung LM, (2008) Activation of estrogen receptor is crucial for resveratrol-stimulating muscular glucose uptake via both insulin-dependent and-independent pathways. Diabetes 57: 1814-1823.
53. Forouhi NG, Luan J, Cooper A, Boucher BJ, Wareham NJ, (2008) Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000. Diabetes 57: 2619-2625.
54. Lee DM, Rutter MK, O'Neill TW, Boonen S, Vanderschueren D, et al. (2009) Vitamin D, parathyroid hormone and the metabolic syndrome in middle-aged and older European men. Eur J Endocrinol 161: 947-954.
55. Reis JP, von Mühlen D, Miller ER 3rd, (2008) Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults. Eur J Endocrinol 159: 41-48.
56. Teegarden D, Donkin SS, (2009) Vitamin D: emerging new roles in insulin sensitivity. Nutr Res Rev 22: 82-92.
57. Alkharfy KM, Al-Daghri NM, Yakout SM, Ahmed M, (2013) Calcitriol attenuates weight-related systemic inflammation and ultrastructural changes in the liver in a rodent model. Basic Clin Pharmacol Toxicol 112: 42-49.
58. Zhu W, Cai D, Wang Y, Lin N, Hu Q, et al. (2013) Calcium plus vitamin D3 supplementation facilitated Fat loss in overweight and obese college students with very-low calcium consumption: a randomized controlled trial. Nutr J 12 (1) (): 8.
59. Rosenblum JL, Castro VM, Moore CE, Kaplan LM, (2012) Calcium and vitamin D supplementation is associated with decreased abdominal visceral adipose tissue in overweight and obese adults. Am J Clin Nutr 95: 101-108.
60. Salehpour A, Hosseinpanah F, Shidfar F, Vafa M, Razaghi M, et al. (2012) A 12-week double-blind randomized clinical trial of vitamin D3 supplementation on body fat mass in healthy overweight and obese women. Nutr J 11: 78.
61. Song Q, Sergeev IN, (2012) Calcium and vitamin D in obesity. Nutr Res Rev 25: 130-141.
62. Scarpellini E, Tack J, (2012) Obesity and metabolic syndrome: an inflammatory condition. Dig Dis 30: 148-153.
63. Nishimura S, Manabe I, Nagai R, (2009) Adipose tissue inflammation in obesity and metabolic syndrome. Discov Med 8: 55-60.
64. Zhuo Q, Wang ZQ, Fu P, Piao JH, Tian Y, et al. (2010) Association between adiponectin and metabolic syndrome in older adults from major cities of China. Biomed Environ Sci 23: 53-61.
65. Van Linthout S, Foryst-Ludwig A, Spillmann F, Peng J, Feng Y, et al. (2010) Impact of HDL on adipose tissue metabolism and adiponectin expression. Atherosclerosis 210: 438-444.
66. Chabrolle C, Tosca L, Ramé C, Lecomte P, Royère D, et al. (2009) Adiponectin increases insulin-like growth factor I-induced progesterone and estradiol secretion in human granulosa cells. Fertil Steril 92: 1988-1996.
67. Rahal OM, Simmen RC, (2011) Paracrine-acting adiponectin promotes mammary epithelial differentiation and synergizes with genistein to enhance transcriptional response to estrogen receptor β signaling. Endocrinology 152: 3409-3421.
68. Wang QP, Yang L, Li XP, Xie H, Liao EY, et al. (2012) Effects of 17β-estradiol on adiponectin regulation of the expression of osteoprotegerin and receptor activator of nuclear factor-κB ligand. Bone 51: 515-23.
69. Hsu HF, Tsou TC, Chao HR, Shy CG, Kuo YT, et al. (2010) Effects of arecoline on adipogenesis, lipolysis, and glucose uptake of adipocytes-A possible role of betel-quid chewing in metabolic syndrome. Toxicol Appl Pharmacol 245: 370-377.
70. Javed F, Al-Hezaimi K, Warnakulasuriya S, (2012) Areca-nut chewing habit is a significant risk factor for metabolic syndrome: a systematic review. J Nutr Health Aging 16: 445-448.
71. Tsai WC, Wu MT, Wang GJ, Lee KT, Lee CH, et al. (2012) Chewing areca nut increases the risk of coronary artery disease in Taiwanese men: a case-control study. BMC Public Health 12: 162.